Stigliano A - Search Results

1

Gandini O, Luci L, Stigliano A, Lucera R, Di Silverio F, Toscano V, Cardillo MR. Gandini O, et al. Among authors: stigliano a. Anticancer Res. 2003 Jan-Feb;23(1A):305-8. Anticancer Res. 2003. PMID: 12680228

2

Correspondence re: J. B. de Kok et al., DD3, A very sensitive and specific marker to detect prostate tumors. Cancer Res., 62: 2695-2698, 2002.

Gandini O, Santulli M, Cardillo MR, Stigliano A, Toscano V. Gandini O, et al. Among authors: stigliano a. Cancer Res. 2003 Aug 1;63(15):4747; author reply 4748-9. Cancer Res. 2003. PMID: 12907658 No abstract available.

3

Thyroid hormones (T3 and T4): dual effect on human cancer cell proliferation.

Moriggi G, Verga Falzacappa C, Mangialardo C, Michienzi S, Stigliano A, Brunetti E, Toscano V, Misiti S. Moriggi G, et al. Among authors: stigliano a. Anticancer Res. 2011 Jan;31(1):89-96. Anticancer Res. 2011. PMID: 21273585

4

Increased metastatic lymph node 64 and CYP17 expression are associated with high stage prostate cancer.

Stigliano A, Gandini O, Cerquetti L, Gazzaniga P, Misiti S, Monti S, Gradilone A, Falasca P, Poggi M, Brunetti E, Aglianò AM, Toscano V. Stigliano A, et al. J Endocrinol. 2007 Jul;194(1):55-61. doi: 10.1677/JOE-07-0131. J Endocrinol. 2007. PMID: 17592021

5

Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.

Monti S, Di Silverio F, Iraci R, Martini C, Lanzara S, Falasca P, Poggi M, Stigliano A, Sciarra F, Toscano V. Monti S, et al. Among authors: stigliano a. J Clin Endocrinol Metab. 2001 Apr;86(4):1700-6. doi: 10.1210/jcem.86.4.7413. J Clin Endocrinol Metab. 2001. PMID: 11297606

6

Mutational analysis of StAR gene in adrenal tumors.

Stigliano A, Caiola S, Siniscalchi E, Papini E, Crescenzi A, Monti S, Arnaldi G, Mantero F, Sciarra F, Toscano V. Stigliano A, et al. Int J Cancer. 2002 Jan 20;97(3):357-60. doi: 10.1002/ijc.1604. Int J Cancer. 2002. PMID: 11774288

7

p53 Stabilization induces cell growth inhibition and affects IGF2 pathway in response to radiotherapy in adrenocortical cancer cells.

Sampaoli C, Cerquetti L, Gawhary RE, Bucci B, Amendola D, Marchese R, Misiti S, Novelli G, Toscano V, Stigliano A. Sampaoli C, et al. Among authors: stigliano a. PLoS One. 2012;7(9):e45129. doi: 10.1371/journal.pone.0045129. Epub 2012 Sep 19. PLoS One. 2012. PMID: 23028800 Free PMC article.

8

Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer.

Cerquetti L, Bucci B, Raffa S, Amendola D, Maggio R, Lardo P, Petrangeli E, Torrisi MR, Toscano V, Pugliese G, Stigliano A. Cerquetti L, et al. Among authors: stigliano a. Front Endocrinol (Lausanne). 2021 May 24;12:667798. doi: 10.3389/fendo.2021.667798. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34108938 Free PMC article.

9

Thyroid hormone receptor TRbeta1 mediates Akt activation by T3 in pancreatic beta cells.

Verga Falzacappa C, Petrucci E, Patriarca V, Michienzi S, Stigliano A, Brunetti E, Toscano V, Misiti S. Verga Falzacappa C, et al. Among authors: stigliano a. J Mol Endocrinol. 2007 Feb;38(1-2):221-33. doi: 10.1677/jme.1.02166. J Mol Endocrinol. 2007. PMID: 17293442

10

3,5,3'-triiodothyronine (T3) is a survival factor for pancreatic beta-cells undergoing apoptosis.

Verga Falzacappa C, Panacchia L, Bucci B, Stigliano A, Cavallo MG, Brunetti E, Toscano V, Misiti S. Verga Falzacappa C, et al. Among authors: stigliano a. J Cell Physiol. 2006 Feb;206(2):309-21. doi: 10.1002/jcp.20460. J Cell Physiol. 2006. PMID: 16021636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters